ArticleScientific reports2025
Association of uric acid to high-density cholesterol ratio (UHR) with biological age acceleration: evidence from NHANES 2009-2018.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Epigenetic Age Acceleration as a Modifiable Public Health Target: A Systematic Review and Meta-Analysis of Environmental, Behavioral, and Social Determinants with Development of the MEAB-Index.International journal of molecular sciences · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The global population is rapidly aging, presenting significant public health challenges, particularly with the increased risk of chronic diseases. Biological age acceleration refers to a faster-than-expected aging process, which is associated with an increased risk of age-related chronic diseases. Uric acid to high-density lipoprotein cholesterol ratio (UHR) is a novel biomarker that reflects metabolic disturbances and has been linked to various chronic conditions. Understanding the relationship between UHR and biological age acceleration, as well as its modifiable risk factors, is crucial for developing strategies aimed at promoting healthy aging and managing chronic diseases in older adults. Using data from a cohort study, the ratio of uric acid to high-density cholesterol (UHR), uric acid (UA), and high-density lipoprotein (HDL) were assessed in relation to biological age acceleration, including phenotypic age acceleration (PhAA) and Klemera-Doubal method age acceleration (KDM-AA), through multiple linear and logistic regression models, adjusted for demographic characteristics, lifestyle factors, and medical histories. Restricted cubic spline (RCS), subgroup, and interaction analyses were also conducted. Subgroups were stratified according to age (< 60 vs. ≥60 years), sex (male vs. female), race (Black vs. others), BMI (< 30 vs. ≥30), hypertension (yes/no), cardiovascular disease (yes/no), cancer (yes/no), and physical activity level (< 600, 600-3999, and ≥ 4000 min/week). The results reveal significant associations between elevated UHR, UA levels, reduced HDL cholesterol, and accelerated biological aging. RCS regression analyses revealed a complex relationship between UHR and age acceleration, with a non-linear association with PhAA and a linear relationship with KDM-AA. Subgroup analysis showed that the association between UHR and biological age acceleration remained robust across all groups. Interaction analyses revealed differential effects across subgroups, particularly among individuals with varying physical activity levels, cardiovascular disease, and hypertension status. This study demonstrates a significant positive association between UHR and markers of biological age acceleration. These findings suggest that UHR could serve as a potential biomarker for aging and chronic disease management in older adults, offering insights into strategies to reduce the burden of age-related conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.